Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01504919 · ClinicalTrials.gov registry record · NA

Reducing Cancer Disparities Among Latinos in Texas

A NA study of Psychosocial Problem, sponsored by M.D. Anderson Cancer Center.

Completed
Registry status
NA
Development phase
301
Enrollment target
2
Study locations

NCT01504919: Completed NA study of Psychosocial Problem, sponsored by M.D. Anderson Cancer Center.

NCT01504919 is a NA study of Psychosocial Problem that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 301 participants, above the 94-participant average among 5 other Psychosocial Problem trials with a reported enrollment target (220% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01504919, a NA study of Psychosocial Problem, has completed, sponsored by M.D. Anderson Cancer Center.

COMPLETED
Registry status
NA
Development phase
301 participants
Enrollment target
2
Study locations

Study Summary

The goal of this research study is to learn if a wellness program can help improve diet and physical activity levels and encourage smoking cessation in Latino individuals who are overweight.

Primary Outcome

Generalized linear mixed model regression (GLMM) used in analyzing the effects of motivation and problem solving (MAPS) on the primary outcomes across the 6, 12, and 18-month time points.

Conditions Studied

Interventions

  • BEHAVIORAL Questionnaires
  • BEHAVIORAL Health Education
  • BEHAVIORAL Telephone Counseling Sessions
  • DRUG Nicotine Patches

Study Locations (2)

Texas

  • William Marsh Rice University - Houston
  • University of Texas MD Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 301 participants
Start Date 2012-01
Est. Completion 2022-01-18
Phase NA
M.D. Anderson Cancer Center

2,692 total trials

What the finished NCT01504919 record still lists

NCT01504919 is an interventional study that assigns participants to a tested intervention. The registered 301 participants enrollment target is mid-sized for trials with a published cap, above the 94-participant average among 5 other Psychosocial Problem trials with a reported enrollment target (220% higher).

The record links to 1 condition, with Psychosocial Problem appearing as the primary indexed condition, and to 4 interventions - of which Questionnaires is the first listed.

NCT01504919 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT01504919 about?

NCT01504919 is a clinical study titled "Reducing Cancer Disparities Among Latinos in Texas". The goal of this research study is to learn if a wellness program can help improve diet and physical activity levels and encourage smoking cessation in Latino individuals who are overweight.

What is the current status of trial NCT01504919?

This trial is currently completed. It is a NA study. The enrollment target is 301 participants. The study started on 2012-01. Estimated completion is 2022-01-18.

What conditions does trial NCT01504919 study?

This clinical trial studies the following conditions: Psychosocial Problem.

What interventions are being tested in trial NCT01504919?

The interventions under investigation include: Questionnaires (BEHAVIORAL), Health Education (BEHAVIORAL), Telephone Counseling Sessions (BEHAVIORAL), Nicotine Patches (DRUG).

Who is sponsoring clinical trial NCT01504919?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01504919 being conducted?

This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Psychosocial Problem

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05005975 · 301 participants · Phase 3

    Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects With Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP)

  • NCT05722561 · 302 participants · Phase 2

    E-Cigarettes for Harm Reduction in Smokers With Opioid Use Disorder

  • NCT06015737 · 302 participants · Phase 3

    A Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus

  • NCT07176273 · 302 participants · NA

    Adaptive Decision-making And Personalized Treatment for PTSD (ADAPT-PTSD)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01504919, the US trial registry maintained by the National Library of Medicine. NCT01504919 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.